FTWA
ADMA icon

Fifth Third Wealth Advisors’s ADMA Biologics ADMA Stock Holding History

Fifth Third Wealth Advisors’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$88.3K Buy
+10,546
New +$96.1K ﹤0.01% 978

Other funds holding ADMA

AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
SOADOR
State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return
LSERS
Louisiana State Employees Retirement System Baton Rouge, Louisiana $5.7B AUM 35.76% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
YCM
Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
FCBT
First Citizens Bank & Trust Raleigh, North Carolina $6.69B AUM 24.48% 1-Year Est. Return

Fifth Third Wealth Advisors's ADMA Position: Q2 2026 in Review

Fifth Third Wealth Advisors opened a new position in ADMA Biologics (ADMA) in Q2 2026: 10,546 shares worth $88.3K. The stake represents ﹤0.01% of the portfolio and ranks #978 among its holdings.

39 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

  • Fifth Third Wealth Advisors held 10,546 shares of ADMA Biologics worth $88.3K as of Q2 2026.
  • ADMA Biologics was a new Fifth Third Wealth Advisors position in Q2 2026.
  • ADMA Biologics made up ﹤0.01% of Fifth Third Wealth Advisors's portfolio in Q2 2026, its #978 holding.
  • 39 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on Fifth Third Wealth Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.